Stock Analysis

The 5B gives an estimated 0.32 quarters of funding, based on cash alone. Oakajee says it could sell its listed investments to fund operations, and that it is confident it could raiseEquityif needed. ItsAnnual General Meetingis on Friday 13 November 2026 and includes a …

That operating progress sits against a weak balance sheet. The FY2026 accounts lodged on 31 August 2026 report net liabilities of about A$18.5 million, and the auditor included a material uncertainty paragraph on going concern. The company says it retains the support of its …

The placement followed a September quarter in which the company ended with only $72,000 in cash, according to its Appendix 4C released on 30 October 2026. That is why funding, rather than the company's operating milestones, is the central issue for shareholders right now.

The financial side is less comfortable. Cash fell to about $712,000 at 30 September 2026 after net operating outflows of $559,000. The company's reported funding runway of 26.32 quarters depends almost entirely on $14 million of undrawn capacity under a redeemable convertible note facility, …

In an announcement on 21 October 2026, the company said portable X-ray fluorescence (pXRF) soil readings had extended the Watsons copper-zinc corridor from about 2.4 kilometres to about 3 kilometres, after a land access agreement opened up an adjoining property. These are field readings …

This change in pace matters because the company's cash is limited. Its Appendix 5B showed $808,000 at 30 September, against quarterly outflows of $503,000. That gives an estimated 1.61 quarters of funding. The executive chairman described a full assessment of the portfolio, with the …

Since then it has drawn new money. On 30 October Adherium announced an additional $750,000Unsecured Loanfacility from Barvest Ventures, a Trudell-related investor, on top of a $700,000 Barvest facility received on 7 October. The company also received a $257,917 milestone payment from AstraZeneca on …